Esperion Therapeutics Inc

0ET

Company Profile

  • Business description

    Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

  • Contact

    3891 Ranchero Drive
    Suite 150
    Ann ArborMI48108
    USA

    T: +1 734 887-3903

    E: [email protected]

    https://www.esperion.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    240

Stocks News & Analysis

stocks

Is CSL undervalued after earnings season wobble?

The ASX's biggest healthcare name saw its shares fall after reporting first-half results.
stocks

After earnings is Apple stock a buy, sell or fairly valued?

Our thoughts on Apple's stock amid slowing iPhone sales but high services revenue.
stocks

Competition impacting ASX market darling

Shares tumble after results.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,799.6048.000.55%
CAC 408,028.9022.680.28%
DAX 4022,037.83126.090.58%
Dow JONES (US)44,593.65123.240.28%
FTSE 1008,777.399.590.11%
HKSE21,812.89518.032.43%
NASDAQ19,643.8670.41-0.36%
Nikkei 22538,963.70162.530.42%
NZX 50 Index12,913.953.50-0.03%
S&P 5006,068.502.060.03%
S&P/ASX 2008,535.3051.300.60%
SSE Composite Index3,346.3928.330.85%

Market Movers